Daiwa Securities Group
VRNA

Daiwa Securities Group’s Verona Pharma VRNA Stock Holding History

Daiwa Securities Group’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-269
Closed -$29K – 1437
2025
Q3 		$29K Hold
269
– – ﹤0.01% 1127
2025
Q2 		$25K Hold
269
– – ﹤0.01% 1093
2025
Q1 		$17K Buy
269
+25
+10% +$1.5K ﹤0.01% 1077
2024
Q4 		$11K Hold
244
– – ﹤0.01% 1116
2024
Q3 		$7K Hold
244
– – ﹤0.01% 1154
2024
Q2 		$4K Hold
244
– – ﹤0.01% 1218
2024
Q1 		$4K Hold
244
– – ﹤0.01% 1229
2023
Q4 		$5K Hold
244
– – ﹤0.01% 1210
2023
Q3 		$4K Hold
244
– – ﹤0.01% 1182
2023
Q2 		$5K Hold
244
– – ﹤0.01% 1188
2023
Q1 		$5K Hold
244
– – ﹤0.01% 1160
2022
Q4 		$6K Buy
+244
New +$3.25K ﹤0.01% 1148

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Daiwa Securities Group's VRNA Position: Q4 2025 in Review

Daiwa Securities Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 269 shares — an estimated $29K sold.

Daiwa Securities Group first reported a position in VRNA in Q4 2022 and held it in 12 quarters. The position peaked at $29K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

  • Daiwa Securities Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 269 Verona Pharma shares in Q4 2025, an estimated $29K.
  • Daiwa Securities Group first reported a position in Verona Pharma in Q4 2022 and held it in 12 quarters.
  • Daiwa Securities Group's Verona Pharma position peaked at $29K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.